NASDAQ:PRPO - Precipio News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.2230 0.00 (0.00 %)
(As of 01/16/2019 09:09 AM ET)
Previous Close$0.2241
Today's Range$0.22 - $0.2430
52-Week Range$0.15 - $1.75
Volume4.11 million shs
Average Volume3.11 million shs
Market Capitalization$6.81 million
P/E RatioN/A
Dividend YieldN/A
Beta0.72

Headlines

Precipio (NASDAQ PRPO) News Headlines

Source:
DateHeadline
Thinking about buying stock in Amarin Corporation, Activision Blizzard, Netflix, Precipio or Tilray?Thinking about buying stock in Amarin Corporation, Activision Blizzard, Netflix, Precipio or Tilray?
www.marketwatch.com - January 11 at 10:07 AM
Precipio Inc.Precipio Inc.
www.barrons.com - January 10 at 10:10 AM
Precipio up 54% on receiving first order for ICP technologyPrecipio up 54% on receiving first order for ICP technology
seekingalpha.com - January 10 at 10:10 AM
Precipio Announces First US Government Customer for ICE COLD-PCR™ Mutation Enrichment TechnologyPrecipio Announces First US Government Customer for ICE COLD-PCR™ Mutation Enrichment Technology
finance.yahoo.com - January 10 at 10:10 AM
Precipio Files Patent for HemeScreen™, its Novel Molecular AssayPrecipio Files Patent for HemeScreen™, its Novel Molecular Assay
globenewswire.com - January 8 at 9:44 AM
 Precipio Files Patent for HemeScreen™, its Novel Molecular Assay Precipio Files Patent for HemeScreen™, its Novel Molecular Assay
finance.yahoo.com - January 8 at 9:44 AM
Precipio Reports Strong Mid-Quarter Growth Nasdaq:PRPO - GlobeNewswirePrecipio Reports Strong Mid-Quarter Growth Nasdaq:PRPO - GlobeNewswire
globenewswire.com - December 13 at 4:40 PM
Precipio Reports Strong Mid-Quarter GrowthPrecipio Reports Strong Mid-Quarter Growth
finance.yahoo.com - December 12 at 5:02 PM
Precipio Announces $1.2 Million Securities Purchase Agreement With Participation from Members of Its Board of Directors, and other InvestorsPrecipio Announces $1.2 Million Securities Purchase Agreement With Participation from Members of Its Board of Directors, and other Investors
finance.yahoo.com - December 4 at 9:43 AM
Precipio ICE COLD-PCR™ Technology Selected by the University of Cincinnati Medical Center for Liquid Biopsy StudyPrecipio ICE COLD-PCR™ Technology Selected by the University of Cincinnati Medical Center for Liquid Biopsy Study
finance.yahoo.com - November 27 at 10:12 AM
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q3 2018 Results - Earnings Call TranscriptPrecipio, Inc. (PRPO) CEO Ilan Danieli on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 20 at 9:22 AM
Letter to Shareholders to accompany recent proxy filingLetter to Shareholders to accompany recent proxy filing
finance.yahoo.com - November 16 at 4:37 PM
Form PRE 14A Precipio, Inc. For: Nov 13Form PRE 14A Precipio, Inc. For: Nov 13
www.streetinsider.com - November 16 at 9:18 AM
Precipio Announces Third Quarter 2018 Corporate Update Call for ShareholdersPrecipio Announces Third Quarter 2018 Corporate Update Call for Shareholders
finance.yahoo.com - November 15 at 9:26 AM
4 Healthcare Stocks To Watch On Wednesday4 Healthcare Stocks To Watch On Wednesday
finance.yahoo.com - November 14 at 4:22 PM
Webinar to Highlight Technology Underlying Precipio’s ICE COLD-PCR on November 20, 2018Webinar to Highlight Technology Underlying Precipio’s ICE COLD-PCR on November 20, 2018
finance.yahoo.com - November 14 at 9:17 AM
Precipio and PerkinElmer Collaborate to Provide Solutions for Liquid Biopsy Testing WorkflowsPrecipio and PerkinElmer Collaborate to Provide Solutions for Liquid Biopsy Testing Workflows
finance.yahoo.com - November 1 at 9:19 AM
Precipio Expands ICE COLD-PCR™ Menu for Breast, Colon and Endometrial CancersPrecipio Expands ICE COLD-PCR™ Menu for Breast, Colon and Endometrial Cancers
finance.yahoo.com - October 23 at 9:34 AM
Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in MediaInnovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media
finance.yahoo.com - October 18 at 9:39 AM
Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 RevenuesPrecipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues
finance.yahoo.com - October 16 at 9:24 AM
Precipio Launches HemeScreen™, a Disruptive, Proprietary Molecular Test for Hematologic CancersPrecipio Launches HemeScreen™, a Disruptive, Proprietary Molecular Test for Hematologic Cancers
finance.yahoo.com - October 3 at 9:27 AM
Form 8-K Precipio, Inc. For: Sep 26Form 8-K Precipio, Inc. For: Sep 26
www.streetinsider.com - September 27 at 4:13 PM
Precipio Granted 180 Day NASDAQ Extension to Regain CompliancePrecipio Granted 180 Day NASDAQ Extension to Regain Compliance
finance.yahoo.com - September 27 at 9:32 AM
Precipio Enters into Exchange Agreement to Restructure Remaining Legacy Accounts Payable for approximately 20 ...Precipio Enters into Exchange Agreement to Restructure Remaining Legacy Accounts Payable for approximately 20 ...
www.nasdaq.com - September 21 at 4:12 PM
Precipio Enters into Exchange Agreement to Restructure Remaining Legacy Accounts Payable for approximately 20% of Original ~$5MPrecipio Enters into Exchange Agreement to Restructure Remaining Legacy Accounts Payable for approximately 20% of Original ~$5M
finance.yahoo.com - September 21 at 9:25 AM
Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection OfferingPrecipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
finance.yahoo.com - September 20 at 9:46 AM
Form 8-K Precipio, Inc. For: Sep 07Form 8-K Precipio, Inc. For: Sep 07
www.streetinsider.com - September 14 at 4:11 PM
Precipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2018 Results - Earnings Call TranscriptPrecipio, Inc. (PRPO) CEO Ilan Danieli on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 23 at 4:15 PM
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter ResultsPrecipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
feeds.benzinga.com - August 22 at 10:21 PM
Precipio Appoints New Board Member to Replace Departing DirectorPrecipio Appoints New Board Member to Replace Departing Director
finance.yahoo.com - August 9 at 9:58 AM
Thinking about buying stock in eBay, Microsoft, Precipio, Square, Inc. or Twitter?Thinking about buying stock in eBay, Microsoft, Precipio, Square, Inc. or Twitter?
www.marketwatch.com - July 19 at 4:06 PM
Today’s Research Reports on Stocks to Watch: Texas Instruments and PrecipioToday’s Research Reports on Stocks to Watch: Texas Instruments and Precipio
finance.yahoo.com - July 19 at 9:11 AM
Precipio reports preliminary Q2 and 1H revenues; shares ahead 65% premarketPrecipio reports preliminary Q2 and 1H revenues; shares ahead 65% premarket
seekingalpha.com - July 18 at 9:02 AM
Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 ResultsPrecipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results
finance.yahoo.com - July 18 at 9:02 AM
Precipio and Nucleai Partner to Develop Artificial Intelligence-Powered Hemepath SolutionPrecipio and Nucleai Partner to Develop Artificial Intelligence-Powered Hemepath Solution
finance.yahoo.com - June 26 at 11:25 AM
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy TechnologyPrecipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
finance.yahoo.com - June 19 at 11:40 AM
Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
finance.yahoo.com - June 12 at 9:24 AM
Precipio announces new U.S. patent portfolio covering ICE-COLD PCR; shares up 9% premarketPrecipio announces new U.S. patent portfolio covering ICE-COLD PCR; shares up 9% premarket
seekingalpha.com - June 6 at 9:45 AM
Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment TechnologyPrecipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
finance.yahoo.com - June 6 at 9:45 AM
Who Owns Most Of Precipio Inc (NASDAQ:PRPO)?Who Owns Most Of Precipio Inc (NASDAQ:PRPO)?
finance.yahoo.com - May 24 at 4:20 PM
Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe with First OrderPrecipio Launches Liquid Biopsy DNA Enrichment Sales in Europe with First Order
finance.yahoo.com - May 24 at 9:48 AM
Potential Sequential Revenue Run-Rate Growth of 30% over Q1, based on Preliminary April ResultsPotential Sequential Revenue Run-Rate Growth of 30% over Q1, based on Preliminary April Results
finance.yahoo.com - May 22 at 9:26 AM
Today’s Research Reports on Stocks to Watch: Precipio and Teva PharmaceuticalToday’s Research Reports on Stocks to Watch: Precipio and Teva Pharmaceutical
finance.yahoo.com - May 15 at 10:17 AM
Precipio Shares Run on Increased Sales in Q1Precipio Shares Run on Increased Sales in Q1
www.baystreet.ca - May 14 at 4:17 PM
Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286%Precipio Announces Preliminary Q1 2018 Year-over-Year Revenue Increase of 286%
finance.yahoo.com - May 14 at 10:35 AM
Precipio announces preliminary Q1 revenues; shares ahead 24% premarketPrecipio announces preliminary Q1 revenues; shares ahead 24% premarket
seekingalpha.com - May 14 at 9:16 AM
Precipio Completes a $3M Convertible Debt FacilityPrecipio Completes a $3M Convertible Debt Facility
finance.yahoo.com - April 23 at 9:23 AM
Precipio (PRPO) Says Its in Strategic Partnership Discussions for IV-CellPrecipio (PRPO) Says It's in Strategic Partnership Discussions for IV-Cell
www.streetinsider.com - April 19 at 9:43 AM
Precipio Launches ICE COLD-PCR™ Research Access Program for Cancer CentersPrecipio Launches ICE COLD-PCR™ Research Access Program for Cancer Centers
finance.yahoo.com - April 11 at 10:22 AM
Precipio Inc (NASDAQ:PRPO): Time For A Financial Health CheckPrecipio Inc (NASDAQ:PRPO): Time For A Financial Health Check
finance.yahoo.com - April 10 at 4:17 PM
This page was last updated on 1/16/2019 by MarketBeat.com Staff

Featured Article: What is the yield curve?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel